Clinical Trials Directory

Trials / Completed

CompletedNCT01591499

Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal

Clinical Evaluation of the Biofinity Multifocal Lens Compared With the Air Optix Aqua Multifocal Lens and With PureVision Multifocal Lens (INNOVATION PRESBYOPIA Study)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
142 (actual)
Sponsor
CooperVision, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, multi-centre, randomised, single-blind, cross-over study to compare the BIOFINITY® MULTIFOCAL lens and respectively the AIR OPTIX® AQUA MULTIFOCAL lens (lenses allocated on a ratio of 1/0.5) and the PUREVISION® MULTIFOCAL lens (lenses allocated on a ratio of 1/0.5), in presbyopic patients.

Detailed description

This is a prospective, multi-centre, randomised, single-blind, cross-over study to compare the BIOFINITY® MULTIFOCAL lens and respectively the AIR OPTIX® AQUA MULTIFOCAL lens (lenses allocated on a ratio of 1/0.5) and the PUREVISION® MULTIFOCAL lens (lenses allocated on a ratio of 1/0.5), in presbyopic patients. Each subject will have 5 visits with the investigator: * (V1) An inclusion visit during which the first pair of lenses are fitted; * (V2) An optimization visit after 7 to 9 days of wearing the first lens; * (V3) An evaluation visit after an additional 10 to 15 days of wearing the first lens (17 to 24 days) and at which time the second pair of lenses are fitted; * (V4, V5) Visits are conducted as in V 2 and V3 with the second pair of lenses.

Conditions

Interventions

TypeNameDescription
DEVICEBIOFINITY® MF - AIR OPTIX® AQUA MFDuring the first period, the participant will be allocated at random either the test lens pair (Biofinity) or a comparator lens pair (Air Optix or Purevision); during the second period, the participant will crossover to the alternate lens pair. (Biofinity crossover to Air Optix or Purevision) (Air Optix or Purevision crossover to Biofinity)
DEVICEBIOFINITY® MF - PUREVISION® MFDuring the first period, the participant will be allocated at random either the test lens pair (Biofinity) or a comparator lens pair (Air Optix or Purevision); during the second period, the participant will crossover to the alternate lens pair. (Biofinity crossover to Air Optix or Purevision) (Air Optix or Purevision crossover to Biofinity)

Timeline

Start date
2011-09-01
Primary completion
2011-12-01
Completion
2012-09-01
First posted
2012-05-04
Last updated
2020-08-11
Results posted
2016-02-08

Source: ClinicalTrials.gov record NCT01591499. Inclusion in this directory is not an endorsement.